Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of ...

Current price $770.33 52-week high $1,211.20 ...

Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...

Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...

Representative Josh Gottheimer also recently made the following trade(s): Shares of REGN stock opened at $778.00 on Friday. The business has a 50-day moving average price of $882.14 and a two-hundred ...

As of November 27 at 12:12:36 PM EST. Market Open.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...